187 related articles for article (PubMed ID: 15792755)
41. Photodynamic effect using a diode laser with mono-l-aspartyl chlorin e6 (NPe6) for implanted mouse tumor.
Katsumi T; Kato H; Okunaka T; Kuroiwa Y; Yoshiteru I; Saito K; Konaka C; Aizawa K
J Clin Laser Med Surg; 1994 Aug; 12(4):211-3. PubMed ID: 10147480
[TBL] [Abstract][Full Text] [Related]
42. Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice.
Katsumi T; Aizawa K; Okunaka T; Kuroiwa Y; Ii Y; Saito K; Konaka C; Kato H
Jpn J Cancer Res; 1994 Nov; 85(11):1165-70. PubMed ID: 7829403
[TBL] [Abstract][Full Text] [Related]
43. Low dose hypericin-PDT induces complete tumor regression in BALB/c mice bearing CT26 colon carcinoma.
Sanovic R; Verwanger T; Hartl A; Krammer B
Photodiagnosis Photodyn Ther; 2011 Dec; 8(4):291-6. PubMed ID: 22122915
[TBL] [Abstract][Full Text] [Related]
44. In vitro and in vivo efficacy of photofrin and pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells.
Hajri A; Wack S; Meyer C; Smith MK; Leberquier C; Kedinger M; Aprahamian M
Photochem Photobiol; 2002 Feb; 75(2):140-8. PubMed ID: 11883602
[TBL] [Abstract][Full Text] [Related]
45. Translating phototherapeutic indices from in vitro to in vivo photodynamic therapy with bacteriochlorins.
Luz AFS; Pucelik B; Pereira MM; Dąbrowski JM; Arnaut LG
Lasers Surg Med; 2018 Jul; 50(5):451-459. PubMed ID: 29714399
[TBL] [Abstract][Full Text] [Related]
46. Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).
Tanaka M; Kataoka H; Yano S; Sawada T; Akashi H; Inoue M; Suzuki S; Inagaki Y; Hayashi N; Nishie H; Shimura T; Mizoshita T; Mori Y; Kubota E; Tanida S; Takahashi S; Joh T
Oncotarget; 2016 Jul; 7(30):47242-47251. PubMed ID: 27363018
[TBL] [Abstract][Full Text] [Related]
47. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
[TBL] [Abstract][Full Text] [Related]
48. CHOP activation by photodynamic therapy increases treatment induced photosensitization.
Wong S; Luna M; Ferrario A; Gomer CJ
Lasers Surg Med; 2004; 35(5):336-41. PubMed ID: 15611953
[TBL] [Abstract][Full Text] [Related]
49. Photobleaching of mono-L-aspartyl chlorin e6 (NPe6): a candidate sensitizer for the photodynamic therapy of tumors.
Spikes JD; Bommer JC
Photochem Photobiol; 1993 Sep; 58(3):346-50. PubMed ID: 8234467
[TBL] [Abstract][Full Text] [Related]
50. Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6.
Nishie H; Kataoka H; Yano S; Yamaguchi H; Nomoto A; Tanaka M; Kato A; Shimura T; Mizoshita T; Kubota E; Tanida S; Joh T
Biochem Biophys Res Commun; 2018 Feb; 496(4):1204-1209. PubMed ID: 29408755
[TBL] [Abstract][Full Text] [Related]
51. Combining vascular and cellular targeting regimens enhances the efficacy of photodynamic therapy.
Chen B; Pogue BW; Hoopes PJ; Hasan T
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1216-26. PubMed ID: 15752904
[TBL] [Abstract][Full Text] [Related]
52. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung.
Kato H; Furukawa K; Sato M; Okunaka T; Kusunoki Y; Kawahara M; Fukuoka M; Miyazawa T; Yana T; Matsui K; Shiraishi T; Horinouchi H
Lung Cancer; 2003 Oct; 42(1):103-11. PubMed ID: 14512194
[TBL] [Abstract][Full Text] [Related]
53. Development of a new minimally invasive phototherapy for lung cancer using antibody-toxin conjugate.
Sonokawa T; Obi N; Usuda J; Sudo Y; Hamakubo T
Thorac Cancer; 2023 Mar; 14(7):645-653. PubMed ID: 36655546
[TBL] [Abstract][Full Text] [Related]
54. [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].
Mori K; Ohta M; Sano A; Yoneya S; Sonoda M; Kaneda A; Sato Y
Nippon Ganka Gakkai Zasshi; 1997 Feb; 101(2):134-40. PubMed ID: 9124093
[TBL] [Abstract][Full Text] [Related]
55. Selenium enhances the efficacy of Radachlorin mediated-photodynamic therapy in TC-1 tumor development.
Kim YW; Bae SM; Liu HB; Kim IW; Chun HJ; Ahn WS
Oncol Rep; 2012 Aug; 28(2):576-84. PubMed ID: 22614712
[TBL] [Abstract][Full Text] [Related]
56. Long-term regression of the murine mammary adenocarcinoma, LM3, by repeated photodynamic treatments using meso-tetra (4-N-methylpyridinium) porphine.
Colombo LL; Vanzulli SI; Villanueva A; Cañete M; Juarranz A; Stockert JC
Int J Oncol; 2005 Oct; 27(4):1053-9. PubMed ID: 16142323
[TBL] [Abstract][Full Text] [Related]
57. Photodynamic therapy (PDT) for lung cancers.
Usuda J; Kato H; Okunaka T; Furukawa K; Tsutsui H; Yamada K; Suga Y; Honda H; Nagatsuka Y; Ohira T; Tsuboi M; Hirano T
J Thorac Oncol; 2006 Jun; 1(5):489-93. PubMed ID: 17409904
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice.
Makowski M; Grzela T; Niderla J; ŁAzarczyk M; Mróz P; Kopeé M; Legat M; Strusińska K; Koziak K; Nowis D; Mrówka P; Wasik M; Jakóbisiak M; Gołab J
Clin Cancer Res; 2003 Nov; 9(14):5417-22. PubMed ID: 14614028
[TBL] [Abstract][Full Text] [Related]
59. Photodynamic therapy upregulates expression of Mac-1 and generation of leukotriene B(4) by human polymorphonuclear leukocytes.
Kobayashi W; Liu Q; Matsumiya T; Nakagawa H; Yoshida H; Imaizumi T; Satoh K; Kimura H
Oral Oncol; 2004 May; 40(5):506-10. PubMed ID: 15006623
[TBL] [Abstract][Full Text] [Related]
60. Tumor regression induced by photodynamic treatment with chlorin p(6) in hamster cheek pouch model of oral carcinogenesis: Dependence of mode of tumor cell death on the applied drug dose.
Dube A; Sharma S; Gupta PK
Oral Oncol; 2011 Jun; 47(6):467-71. PubMed ID: 21550293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
